Clinical Trial

Safety and Quality of Life of Three Treatment Strategies for Low-Risk Papillary Thyroid Microcarcinoma

Study acronym: PTMC-3S
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective observational patient registry study designed to evaluate the safety and quality of life associated with three treatment strategies for patients diagnosed with low-risk papillary thyroid microcarcinoma (PTMC): surgical resection, thermal ablation, and active surveillance. The study aims to collect standardized, real-world clinical data from participating centers. Patients will receive one of the three treatment strategies according to clinical judgment and personal preference. The study team will prospectively follow participants to record safety events, disease progression, and patient-reported quality of life outcomes. By comparing the outcomes among the three treatment groups, this registry seeks to provide evidence to support personalized and evidence-based decision-making for the management of low-risk PTMC.
Trial Details
NCT Number NCT07249125
Lead Sponsor Xijing Hospital
Conditions Papillary Thyroid Microcarcinoma
Enrollment 1,630 participants
Start Date 2025-12-01
Primary Completion 2038-12-31 (estimated)
Study Completion 2039-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-25